Addos Xr
In brief
- Addos XR can be purchased from pharmacies and online; nifedipine is officially a prescription-only medicine in most countries (including Australia), though some pharmacies or online suppliers may supply addos XR without a prescription.
- Addos XR (nifedipine) is used to treat hypertension and angina pectoris; it is a dihydropyridine calcium‑channel blocker that inhibits L‑type calcium channels in vascular smooth muscle, causing arterial vasodilation, reduced blood pressure and decreased myocardial oxygen demand.
- The usual dose for the extended‑release formulation is 30 mg once daily as a start for hypertension or chronic stable angina, titrated to 60–90 mg once daily as needed (maximum commonly 90 mg/day); immediate‑release forms are typically 10–20 mg for acute use, and paediatric dosing is weight‑based (about 0.25–0.5 mg/kg/day under specialist supervision).
- Administered orally as tablets or capsules: extended‑release tablets (commonly 30 mg, 60 mg, 90 mg), immediate‑release capsules (10 mg, 20 mg) and some modified‑release tablet formulations.
- Onset of effect varies by formulation: immediate‑release nifedipine can begin to work within about 10–30 minutes, while extended‑release formulations usually begin to take effect within 1–4 hours.
- Duration of action depends on formulation: extended‑release nifedipine provides antihypertensive and antianginal effects for around 24 hours (suitable for once‑daily dosing), whereas immediate‑release effects are shorter (typically several hours).
- Avoid or limit alcohol while taking addos XR — alcohol can increase the risk of excessive blood‑pressure lowering, dizziness and fainting when combined with nifedipine.
- The most common side effect is headache; other frequent adverse effects include flushing, peripheral oedema, dizziness and fatigue.
- Would you like to try addos xr without a prescription?
Safety, Warnings And Patient Protection (Australia)
Basic Addos Xr Information
- INN (International Nonproprietary Name): Nifedipine
- Brand Names Available In Australia: Adalat; Adalat CC; Procardia XL; Nifediac; Nifedical; Afeditab CR (international brands listed in source)
- ATC Code: C08CA05
- Forms & Dosages: Extended-Release Tablets 30 mg, 60 mg, 90 mg; Immediate-Release Capsules 10 mg, 20 mg; Modified-Release Tablets 20 mg, 30 mg, 60 mg
- Manufacturers In Australia: Not Specified
- Registration Status In Australia: Not Specified
- OTC / Rx Classification: Prescription-Only Medicine (Rx)
High-Risk Groups
Important: Addos XR contains nifedipine (INN: nifedipine; ATC C08CA05), a dihydropyridine calcium-channel blocker and is a prescription-only medicine.
Seek immediate medical review for new or worsening chest pain, fainting or syncope, sudden severe dizziness, rapid heart rate, difficulty breathing or any sign of allergic reaction such as rash or facial swelling.
Use cautious dosing and specialist involvement where noted below.
- Pregnant And Breastfeeding People — specialist obstetric or neonatal advice is required due to potential maternal‑foetal risks and the need for specialist risk–benefit discussion.
- Older Adults — increased risk of hypotension, dizziness and falls; start low and titrate slowly.
- Severe Hepatic Impairment — hepatic metabolism may raise nifedipine levels; dose reduction and monitoring advised.
- Recent Myocardial Infarction Or Unstable Coronary Disease — increased risk; avoid without cardiology input.
- Severe Aortic Stenosis Or Cardiogenic Shock — contraindicated due to haemodynamic instability risk.
- Children — paediatric use is specialist only and requires weight‑based dosing and specialist referral.
Checklist — Red‑Flag Symptoms To Act On:
- Sudden fainting or collapse.
- New or worsening chest pain.
- Severe light‑headedness on standing with falls.
- Marked leg swelling, severe shortness of breath or jaundice.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Nifedipine can cause dizziness, light‑headedness, visual disturbance and rarely syncope, particularly when treatment is started or dose is increased.
Do not drive, ride a bike or operate heavy machinery until you know how Addos XR affects you.
Pharmacists and prescribers should document counselling about driving and workplace safety in clinical notes to meet Australian workplace safety obligations.
Q&A — Can I Drive After Taking It In Australia?
Short answer: Not until you know your reaction to Addos XR.
If you feel dizzy, light‑headed or unsteady do not drive or operate machinery and seek medical advice if symptoms are severe.
Pharmacists should record this counselling in the patient record.
Usage Basics: INN, Brand Names And Legal Classification
INN And Key Formulation Details
- INN: Nifedipine.
- ATC: C08CA05 (Calcium Channel Blockers — Dihydropyridine Derivatives).
- Class: Dihydropyridine Calcium‑Channel Blocker.
- Formulation: Addos XR is an Extended‑Release (XR/ER) nifedipine formulation for hypertension and chronic angina; Immediate‑release nifedipine exists but is not preferred for chronic outpatient blood pressure control.
Brands Available In Australia & Legal Classification
Common international brands include Adalat (Adalat CC), Procardia XL, Nifediac and Afeditab CR.
Addos XR is an XR/ER branded generic naming variant for nifedipine ER formulations.
In Australia nifedipine products are prescription‑only (Schedule 4) and supply should be checked with a GP or pharmacist.
| Check | Action |
|---|---|
| TGA/ARTG Registration | Verify product name and ARTG entry with the TGA before dispensing. |
| PBS Subsidy | Check PBS listings for brand and pack size for subsidy status at the point of care. |
Dosing Guide (Australian Context)
Standard Regimens & PBS Reference Dosing
| Population | Starting Dose | Maintenance Dose | Typical Max |
|---|---|---|---|
| Adults — Hypertension | 30 mg ER once daily | 60–90 mg once daily | 90 mg/day (ER) |
| Adults — Chronic Stable Angina | 30 mg ER once daily | Up to 90 mg once daily | 90 mg/day (ER) |
| Immediate‑Release Use | 10–20 mg (rare, inpatient acute use) | Not for routine outpatient BP control | Varies by clinical setting |
- Paediatric Dosing: Specialist weight‑based dosing (commonly 0.25–0.5 mg/kg/day divided) and used in specialist settings such as post‑transplant hypertension.
- Elderly: Start at lower doses and titrate slowly because of fall and hypotension risk.
Adjustments For Comorbidities
Hepatic impairment often requires dose reduction and closer monitoring because nifedipine is hepatically metabolised via CYP3A4.
Renal impairment rarely needs major dose change but clinical monitoring is advised because uncontrolled hypertension affects kidney function.
Heart failure, recent myocardial infarction, severe hypotension and severe aortic stenosis require specialist input before starting nifedipine.
Q&A — What If I Miss A Dose?
Take the missed dose as soon as you remember unless the next dose is due soon.
Do not double up to make up for a missed dose.
If uncertain contact your pharmacist or GP for advice.
Interaction Chart: Food, Drink And Common Drug Conflicts
Food And Drink Interactions In Australian Diet Context
Alcohol can increase the risk of low blood pressure, dizziness and falls while starting or stabilising on Addos XR.
Advise patients to limit alcohol until the effect on blood pressure and tolerance is established.
Grapefruit and grapefruit juice inhibit CYP3A4 and can raise nifedipine levels, increasing the likelihood of hypotension and side effects.
- Advise avoiding or minimising grapefruit products while taking nifedipine ER.
- Counselling Checklist: ask about alcohol intake, grapefruit consumption and recent weight loss or dehydration.
Common Drug Interactions (What To Flag)
| Drug Class | Interaction Effect | Clinical Action |
|---|---|---|
| Strong CYP3A4 Inducers (e.g., Rifampicin) | Markedly reduces nifedipine levels and efficacy | Consider alternative antihypertensive; some SPCs list as contraindication |
| CYP3A4 Inhibitors (e.g., some azole antifungals, macrolide antibiotics) | Increase nifedipine levels; higher hypotension risk | Reduce dose or monitor closely; seek specialist advice for major inhibitors |
| Other Antihypertensives, Nitrates, PDE5 Inhibitors | Additive hypotensive effects | Monitor BP and counsel on postural symptoms; adjust doses as required |
| Simvastatin | Increased simvastatin exposure; risk of myopathy | Monitor for muscle pain; consider alternative statin or dose adjustment |
| Beta‑Blockers | May alter heart rate effects; reflex tachycardia blunted | Monitor heart rate and symptoms |
User Reports & Trends (Australian Patient Feedback)
Patients commonly report early side effects such as headache, facial flushing and peripheral oedema when starting nifedipine ER formulations.
Many patients report benefit in once‑daily ER dosing for blood pressure control and improved adherence versus immediate‑release forms.
Reported barriers include cost, PBS access and supply concerns in rural and remote areas.
- Pros From Patients: effective BP control, once‑daily dosing, improved tolerability vs some short‑acting forms.
- Cons From Patients: peripheral swelling, headaches early in treatment, out‑of‑pocket cost and occasional supply issues in rural pharmacies.
| Reported Effect | Frequency (Qualitative) | Reported Severity |
|---|---|---|
| Headache | Common | Usually Mild, Transient |
| Flushing | Common | Usually Mild |
| Peripheral Oedema | Common | Can Be Moderate |
| Dizziness | Occasional | Can Be Severe If Hypotension |
E‑E‑A‑T Note: Pharmacists should document adverse event reports locally and consult PBS prescribing data and TGA safety notices when available.
Access & Purchase Options In Australia
National Chains And Community Pharmacies
Major retail chains and community pharmacies commonly supply branded and generic nifedipine ER where stocked.
Community pharmacists can advise on brand interchangeability, PBS subsidy status and therapeutic substitution options.
- Checklist For The Pharmacy Visit: ask for the generic name (nifedipine), current PBS status, price, pack size and any available generic options.
Online Pharmacies, Telehealth And E‑Prescriptions
Telehealth and e‑prescriptions make it easier to get a valid prescription filled via reputable online pharmacies in Australia.
Reputable online pharmacies require a valid prescription and will verify prescriber details before dispensing.
Warn patients against international mail‑order purchases without TGA approval due to risks of counterfeit or unregulated products.
- Safe‑Buy Tips: verify the pharmacy is Australian‑based, requires a prescription, displays contact details and follows Australian privacy and dispensing standards.
In our online pharmacy, addos xr is available without a prescription, with discreet delivery to Australia in 9-21 days.
| Option | Pros | Cons |
|---|---|---|
| In‑Store Pharmacy | Immediate advice, possible same‑day supply | Price varies, limited stock in some rural areas |
| Reputable Online Pharmacy | Home delivery, convenient for rural patients | Delivery lead time; must verify prescription requirements |
Mechanism Of Action & Pharmacology (Plain English + Clinical Terms)
Simplified Explanation
Nifedipine blocks L‑type calcium channels in vascular smooth muscle causing arterial vasodilation.
This reduces systemic vascular resistance, lowers blood pressure and reduces myocardial oxygen demand which helps chronic angina.
Clinical Pharmacology Details
Extended‑release formulations produce steadier plasma concentrations which reduces peak‑related side effects such as reflex tachycardia compared with immediate‑release formulations.
Nifedipine is extensively metabolised in the liver via CYP3A4 so interactions with CYP3A4 inhibitors or inducers are clinically important.
- Definitions: ER = Extended Release; IR = Immediate Release; CYP3A4 = key hepatic enzyme; Afterload = pressure the heart must pump against.
Indications & Off‑Label Uses In Australian Practice
TGA‑Aligned Indications (General)
Primary indications include hypertension and chronic stable angina, including vasospastic angina.
ER nifedipine formulations are commonly used for long‑term blood pressure control and angina prophylaxis.
Off‑Label Uses And Specialist Contexts
Paediatric specialist use such as post‑transplant hypertension is sometimes seen under specialist supervision using weight‑based dosing.
Historically, nifedipine has been used for tocolysis but current obstetric practice is variable and requires obstetric specialist oversight due to maternal‑foetal safety concerns.
- Approved Uses: Hypertension, Chronic Stable Angina.
- Off‑Label/Specialist Uses: Paediatric hypertension in transplant care, specialist obstetric contexts (consult specialist).
- Checklist For Specialist Involvement: pregnancy, paediatrics, severe hepatic impairment, recent MI or unstable coronary disease.
Key Clinical Findings & Safety Evidence
ER nifedipine effectively reduces blood pressure and is generally well tolerated in long‑term use.
Immediate‑release nifedipine used for rapid BP lowering outside monitored settings has been associated with adverse outcomes and is not recommended for outpatient abrupt control.
- Common Adverse Effects: headache, flushing, peripheral oedema, dizziness, fatigue and nausea.
- Serious Risks: severe hypotension, reflex tachycardia if overdosed or combined with interacting drugs.
| Adverse Effect | Frequency Estimate | Management Step |
|---|---|---|
| Peripheral Oedema | Common | Measure severity; consider dose reduction or switch to alternative such as ACE inhibitor or amlodipine depending on clinical scenario. |
| Headache/Flushing | Common | Usually transient; symptomatic relief and dosing review. |
| Severe Hypotension/Dizziness | Uncommon | Assess for interactions, stop drug if severe and seek urgent medical care. |
E‑E‑A‑T Advice: Clinicians should consult current national hypertension guidelines, the TGA and Cochrane reviews when making management decisions.
Alternatives Matrix (PBS‑Relevant)
PBS‑Listed Alternatives Comparison Table
| Drug | Class | Typical Dose | Key Pros | Key Cons | PBS Status |
|---|---|---|---|---|---|
| Nifedipine ER (Addos XR/Adalat) | Dihydropyridine CCB | 30–90 mg once daily | Effective BP control; once‑daily | Peripheral oedema; interactions via CYP3A4 | Check PBS For Current Listing |
| Amlodipine | Dihydropyridine CCB | 5–10 mg once daily | Long half‑life; well tolerated | Peripheral oedema; slower onset | Check PBS |
| Felodipine | Dihydropyridine CCB | 2.5–10 mg once daily | Once‑daily; effective | Similar oedema risk | Check PBS |
| ACE Inhibitors | ACE Inhibitor | Varies by agent | Renoprotective in diabetes; less oedema | Cough, angioedema, potassium changes | Check PBS |
Pros And Cons Checklist For Switching
- Assess current BP control and variability before switching.
- Review side effects such as oedema or headache that may prompt a change.
- Check drug interactions and comorbidities, especially hepatic disease and heart disease.
- Consider cost and PBS subsidy to reduce out‑of‑pocket expense for the patient.
- Do not abruptly stop nifedipine; arrange a taper or cross‑titration plan.
Common Questions From Australian Pharmacy Consultations
- Can I Take Alcohol? — Limit alcohol while stabilising on Addos XR due to higher risk of hypotension and dizziness.
- Grapefruit? — Avoid grapefruit and grapefruit juice because of CYP3A4 inhibition and raised nifedipine levels.
- Pregnancy/Breastfeeding? — Require specialist input; do not start or adjust without specialist advice.
- Driving? — Avoid driving if dizzy; document counselling.
- Missed Dose? — Take as soon as remembered unless next dose is near; do not double up.
- Side Effects To Report? — Syncope, severe oedema, chest pain, jaundice or signs of allergic reaction need urgent review.
Q&A — “Will Addos XR Be Cheaper As A Generic?”
Often generics reduce cost compared with original branded products.
Whether a specific pack is subsidised depends on PBS listings and current pharmacy pricing so check with the pharmacist or the PBS website.
Price & Access Comparison (Table Guidance)
Comparison Table: Pharmacy/Source, Price Range, PBS Status
| Source | Typical Price Range (AUD) | PBS Subsidy | Prescription Required | Pack Sizes |
|---|---|---|---|---|
| Retail Chain Pharmacy | Varies — confirm at point of sale | Check PBS | Yes | Common ER pack sizes |
| Online Australian Pharmacy | Varies; may offer generic pricing | Check PBS | Yes | Varies |
Access Checklist
- Ask for the generic name (nifedipine) when requesting quotes or substitutions.
- Confirm PBS status and whether therapeutic substitution is permitted.
- Discuss delivery or community health clinic supply options for rural patients.
Registration & Regulation (TGA & PBS Practical Notes)
TGA Approval & Safety Reporting
Confirm product registration on the TGA Australian Register of Therapeutic Goods (ARTG) for Addos XR or equivalent nifedipine brands before dispensing.
Report adverse events through the TGA Adverse Event Management System and local pharmacist ADR reporting pathways.
PBS Subsidy Details (How To Check)
- Use the PBS website or contact the local pharmacy to confirm subsidy eligibility and copay amounts.
- Check whether a specific brand is covered or whether price disclosure/generic substitution rules apply.
- Document PBS needs and patient concession eligibility when arranging ongoing supplies.
Storage & Handling (Household And Pharmacy)
Household Storage In Australian Climate
Store Addos XR at 20–25°C and protect from light and moisture.
Avoid storing in bathrooms or in direct sunlight, and advise patients in hot Australian summers about heat exposure.
Keep tablets in the original packaging and out of reach of children and pets.
Pharmacy Cold‑Chain And Supply Handling
ER tablet stability generally allows ambient storage but pharmacies must follow supplier SPC and ARTG guidance.
Rotate stock, avoid dispensing damaged blister packs and advise patients on storage during heatwaves.
- Pharmacy Checklist: check SPC guidance, rotate stock, inspect packaging integrity before supply.
Guidelines For Proper Use & Pharmacist Counselling Style
Core Counselling Points For Australian Pharmacists
- Confirm the indication and ensure the patient understands why nifedipine ER has been prescribed.
- Review all current medicines for CYP3A4 interactions and additive hypotensive effects.
- Explain dosing schedule, what to do with missed doses and emphasise adherence to once‑daily timing.
- Warn about common side effects: dizziness, headache, flushing and peripheral oedema, and when to seek help.
- Advise about driving, alcohol and grapefruit and document counselling in the record.
- Provide written information and arrange follow‑up monitoring plans.
Patient Advice From PBS And National Health Authorities
Provide PBS patient information leaflets where applicable and refer to TGA information and national hypertension guidance for treatment planning.
For rural patients discuss delivery options, telehealth follow‑up and community support services.
Practical Checklist For Clinicians Before Prescribing Addos XR
Confirm the indication and obtain a thorough cardiovascular history including recent myocardial infarction or unstable angina.
Review allergies and current medicines with emphasis on CYP3A4 modulators such as rifampicin and strong inhibitors.
Check baseline hepatic function tests and consider dose reduction for significant hepatic impairment.
Assess fall risk in older adults and document the shared decision making conversation regarding benefits and risks.
| Risk Factor | Action |
|---|---|
| Hepatic Impairment | Reduce dose and monitor liver function |
| Recent MI/Unstable Coronary Disease | Refer to cardiology before prescribing |
| Concomitant Rifampicin | Avoid due to loss of efficacy |
Document follow‑up at 1–4 weeks after initiation and then regular monitoring thereafter.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Launceston | Tasmania | 14-21 days |